Payer+Provider's Health System Review
December 14, 2021
Markets were down for the second day in a row ahead of a big Fed decision.
December 9, 2021
Although its shares have lagged other vaccine makers in 2021, Pfizer could soon be poised for significant revenue growth.
December 6, 2021
The market rebounded strongly after last week’s omicron-induced sell-off.
December 3, 2021
Some of the pandemic’s hottest stay-at-home stocks have undergone brutal sell-offs this year.
August 17, 2021
Covid’s Forgotten Hero: The Untold Story Of The Scientist Whose Breakthrough Made The Vaccines Possible
March 19, 2021
Pascal Soriot’s stunning corporate turnaround story at AstraZeneca is now mired in vaccine politics and doubt.
March 12, 2021
Delivering a game-changing vaccine was a sprint. Bourla says delivering returns for Pfizer shareholders is a marathon.
November 16, 2020
Pfizer’s vaccine is promising, but this news will change the dynamic in markets, and could make the spread of the virus worse in the short-term
October 31, 2020
The last week has been beset by a lot of bad news and negative forecasts, we need however to look to the long-term and to consider the effect on mental health of lockdowns.
September 28, 2020
Stocks are rallying to end a dismal month.